))
Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications
Manage episode 446536581 series 3610272
Content provided by Arthritis Consumer Experts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Arthritis Consumer Experts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Derin Karacabeyli, rheumatology resident at the University of British Columbia. Dr. Karacabeyli is studying the effects of treating metabolic comorbidities like obesity and type 2 diabetes on patients with immune-mediated inflammatory diseases. In this interview, he shares the work he is conducting to look at the potential risks and benefits for inflammatory arthritis patients taking a new class of medications used in type 2 diabetes therapy.
Additional learning resources
119 episoade
Distribuie
